zidovudine

In pregnant women, the antiviral zidovudine, also known as AZT, was tested against a placebo to see whether it blocked mother-to-child HIV transmission.

For four to six weeks their baby will receive a medicine called zidovudine, which will reduce the likelihood of HIV transmission.

In this case, the girl was given the drug zidovudine as a preventive measure for six weeks after birth, when treatment was suspended.

By contrast, the French patient was initially treated for 6 weeks with a single drug, zidovudine.

Doctors gave the baby an HIV drug - zidovudine, or AZT - for six weeks, which was the standard of care at that time.